Xconomy’s Digital Events →
New York-based Intercept Pharmaceuticals is developing drugs for chronic liver diseases.
Sponsored · Video
A Fireside Chat with Biocom President & CEO Joe Panetta
From Our Editors · Special Report
The AI, Big Data, and R&D Boom
Sponsored · Whitepaper
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.